InvestorsObserver
×
News Home

Will SCYNEXIS Inc (SCYX) Outperform the Rest of the Stocks in the Healthcare Sector?

Wednesday, September 27, 2023 01:40 PM | InvestorsObserver Analysts

Mentioned in this article

Will SCYNEXIS Inc (SCYX) Outperform the Rest of the Stocks in the Healthcare Sector?

SCYNEXIS Inc (SCYX) is near the top in its sector according to InvestorsObserver. SCYX gets an overall rating of 34. That means it scores higher than 34% of stocks. SCYNEXIS Inc gets a 77 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Overall Score - 34
SCYX has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on SCYX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With SCYNEXIS Inc Stock Today?

SCYNEXIS Inc (SCYX) stock is up 6.25% while the S&P 500 has fallen -0.64% as of 1:38 PM on Wednesday, Sep 27. SCYX has risen $0.12 from the previous closing price of $1.93 on volume of 457,651 shares. Over the past year the S&P 500 is up 16.42% while SCYX has fallen -10.87%. SCYX earned $0.81 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 2.52. Click Here to get the full Stock Report for SCYNEXIS Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App